Published in Cancer Lett on January 10, 2003
Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation. Am J Physiol Cell Physiol (2009) 1.46
Computational Studies of the Effect of Shock Waves on the Binding of Model Complexes. J Chem Theory Comput (2014) 0.75
The search for synergy: a critical review from a response surface perspective. Pharmacol Rev (1995) 8.24
Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res (1999) 3.05
Ribosome-inactivating proteins from plants. Biochim Biophys Acta (1993) 2.97
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res (1999) 1.56
Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer (1988) 1.35
Cytoplasmic molecular delivery with shock waves: importance of impulse. Biophys J (2000) 1.20
Shock wave-mediated molecular delivery into cells. Biochim Biophys Acta (2002) 1.19
In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. Int J Cancer (2001) 1.18
Scavenger-receptor targeted photodynamic therapy. Photochem Photobiol (2000) 1.10
Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer (2000) 1.08
Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro. Cancer Lett (1988) 1.08
Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors. Int J Radiat Oncol Biol Phys (1988) 1.08
Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res (1995) 1.02
Permeabilization of the plasma membrane of L1210 mouse leukemia cells using lithotripter shock waves. J Membr Biol (1994) 0.99
Saporin immunotoxins. Curr Top Microbiol Immunol (1998) 0.90
Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy. Cancer Res (1999) 0.88
Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Br J Cancer (2001) 0.82
Stress-wave-assisted transport through the plasma membrane in vitro. Lasers Surg Med (1997) 0.81
Stress-wave-induced membrane permeation of red blood cells is facilitated by aquaporins. Ultrasound Med Biol (1997) 0.81
Cell loading with laser-generated stress waves: the role of the stress gradient. Pharm Res (1999) 0.79
Monoclonal antibody therapies for lymphomas. Cancer J (2001) 0.78
Augmented inhibition of tumor cell proliferation in combined use of electroporation with a plant toxin, saporin. Ann N Y Acad Sci (1999) 0.78
Augmentation of antiproliferative and antitumor effect on human cancer cells in combined use of electroporation with a plant toxin, saporin. Cancer Biother Radiopharm (2001) 0.78
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer (2006) 3.93
Biphasic dose response in low level light therapy. Dose Response (2009) 2.78
The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng (2011) 2.37
Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med (2004) 2.12
Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother (2005) 1.89
Role of low-level laser therapy in neurorehabilitation. PM R (2010) 1.79
Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One (2011) 1.76
Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther (2009) 1.73
Biphasic dose response in low level light therapy - an update. Dose Response (2011) 1.69
Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother (2006) 1.58
Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci (2004) 1.57
Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials (2006) 1.51
Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother (2009) 1.50
Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B (2005) 1.50
Photodynamic treatment of endodontic polymicrobial infection in vitro. J Endod (2008) 1.48
Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod (2007) 1.46
Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players. Lasers Med Sci (2015) 1.46
Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) (2011) 1.45
Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med (2010) 1.45
Can surgical site infections be treated by photodynamic therapy? Photodiagnosis Photodyn Ther (2010) 1.43
Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat (2012) 1.42
Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother (2005) 1.42
Photodynamic therapy for infections: clinical applications. Lasers Surg Med (2011) 1.42
Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg (2010) 1.38
Photodynamic therapy for endodontic disinfection. J Endod (2006) 1.38
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic Biol Med (2007) 1.37
Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time. Lasers Surg Med (2007) 1.36
Low-level light stimulates excisional wound healing in mice. Lasers Surg Med (2007) 1.36
Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct (2009) 1.35
Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg (2013) 1.34
Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med (2007) 1.33
Photodynamic therapy with fullerenes. Photochem Photobiol Sci (2007) 1.32
Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med (2010) 1.32
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol (2005) 1.28
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A (2008) 1.23
Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev Anti Infect Ther (2011) 1.23
Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother (2006) 1.22
Effect of pulsing in low-level light therapy. Lasers Surg Med (2010) 1.21
Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One (2011) 1.21
Shock wave-mediated molecular delivery into cells. Biochim Biophys Acta (2002) 1.19
Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med (2005) 1.15
Comparison of therapeutic effects between pulsed and continuous wave 810-nm wavelength laser irradiation for traumatic brain injury in mice. PLoS One (2011) 1.15
Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers Surg Med (2012) 1.15
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res (2009) 1.14
Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev (2013) 1.13
Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med (2010) 1.12
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One (2010) 1.12
Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One (2012) 1.12
Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice. Wound Repair Regen (2008) 1.11
Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11
Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria. Lasers Surg Med (2012) 1.11
Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol (2010) 1.11
Photodynamic inactivation of Enterococcus faecalis in dental root canals in vitro. Lasers Surg Med (2007) 1.11
Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol (2006) 1.11
Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother (2010) 1.10
Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. PLoS One (2013) 1.10
Photochemical activation of TRPA1 channels in neurons and animals. Nat Chem Biol (2013) 1.09
Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother (2008) 1.09
Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) (2010) 1.09
Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med (2013) 1.08
Chitosan acetate bandage as a topical antimicrobial dressing for infected burns. Antimicrob Agents Chemother (2008) 1.07
Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother (2011) 1.07
Animal models of external traumatic wound infections. Virulence (2011) 1.07
Photodynamic therapy with fullerenes in vivo: reality or a dream? Nanomedicine (Lond) (2011) 1.07
Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther (2012) 1.07
Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother (2012) 1.07
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light. Photonics Lasers Med (2012) 1.07
Dose response effects of 810 nm laser light on mouse primary cortical neurons. Lasers Surg Med (2011) 1.06
Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study. J Neurotrauma (2014) 1.05
Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother (2007) 1.05
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion. Lasers Surg Med (2012) 1.05
Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol (2005) 1.02
Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg (2013) 1.02
Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol (2013) 1.02
Non-invasive evaluation of the kinetics of allergic and irritant contact dermatitis. J Invest Dermatol (2005) 1.01
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J (2013) 1.01
Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals. Free Radic Biol Med (2012) 1.00
Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease. Photomed Laser Surg (2011) 1.00
Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma. PLoS One (2007) 1.00
Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine (2009) 1.00
Photodestruction of human dental plaque bacteria: enhancement of the photodynamic effect by photomechanical waves in an oral biofilm model. Lasers Surg Med (2003) 1.00
Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg Med (2009) 1.00
Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro. J Biophotonics (2012) 0.99
Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production. Cancer Lett (2009) 0.99
Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care (2012) 0.98
Low level laser therapy increases angiogenesis in a model of ischemic skin flap in rats mediated by VEGF, HIF-1α and MMP-2. J Photochem Photobiol B (2013) 0.98
In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. J Med Chem (2010) 0.98
Introduction to experimental and clinical studies using low-level laser (light) therapy (LLLT). Lasers Surg Med (2010) 0.97
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol (2014) 0.97
Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol (2010) 0.97
Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery. Adv Skin Wound Care (2012) 0.95
Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother (2011) 0.95
Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna-C(60) contact and effective photodynamic potential. J Mater Chem (2010) 0.95
Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion in mice. Lasers Med Sci (2013) 0.95